基于MRI的简化前列腺外侵犯评估:不同预测模型性能比较
本研究纳入65例根治性前列腺切除术前接受1.5T多参数MRI的患者,由7名放射科医生独立评估简化前列腺外侵犯评分(sEPE grade),并测量指数病灶直径(dIL)。结果显示sEPE评分可重复性好,与二值化dIL*联合预测病理EPE的ROC-AUC达0.81。
要点
- sEPE评分基于包膜接触长度>15mm和包膜膨隆/不规则,可重复性好。
- sEPE评分联合dIL*预测前列腺外侵犯的AUC为0.81。
- sEPE评分预测效能不受读者经验影响。
核心结论
- sEPE评分具有可重复性,与dIL*联合可准确预测前列腺外侵犯。
研究设计与样本
- 单中心研究纳入65例前列腺癌根治术前6个月内行1.5T多参数MRI的患者,平均年龄67岁±6.3。
- 由7名放射科医生独立评估sEPE评分、包膜接触长度≥15mm、dIL*和包膜膨隆/不规则,采用加权Cohen K系数检验读者间一致性。
- 采用嵌套蒙特卡洛交叉验证,以Youden J指数选择dIL最佳截断值生成二值变量dIL*,建立逻辑回归模型预测病理EPE,用ROC和决策曲线分析评估验证集。
关键影像表现/征象
- sEPE评分由MRI指标包膜接触长度>15mm和包膜膨隆/不规则推导而来。
- 病理EPE见于31/65(48%)患者。
诊断标准与关键数值
- sEPE评分、包膜接触长度≥15mm、dIL*和包膜膨隆/不规则的加权Kappa分别为0.65(95%CI 0.51-0.79)、0.66(95%CI 0.48-0.84)、0.67(95%CI 0.50-0.84)和0.43(95%CI 0.22-0.63)。
- sEPE评分联合dIL*预测EPE的ROC-AUC最高,为0.81。
临床应用与阅片要点
- sEPE评分可重复性好,且预测效能不受读者经验影响,适合日常术前分期评估。
- 结合sEPE评分与dIL*可提高前列腺外侵犯的预测准确性,辅助风险分层。
局限性
- 单中心小样本研究(65例),需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To test reproducibility and predictive value of a simplified score for assessment of extraprostatic tumor extension (sEPE grade).
METHODS: Sixty-five patients (mean age ± SD, 67 years ± 6.3) treated with radical prostatectomy for prostate cancer who underwent 1.5-Tesla multiparametric magnetic resonance imaging (mpMRI) 6 months before surgery were enrolled. sEPE grade was derived from mpMRI metrics: curvilinear contact length > 15 mm (CCL) and capsular bulging/irregularity. The diameter of the index lesion (dIL) was also measured. Evaluations were independently performed by seven radiologists, and inter-reader agreement was tested by weighted Cohen K coefficient. A nested (two levels) Monte Carlo cross-validation was used. The best cut-off value for dIL was selected by means of the Youden J index to classify values into a binary variable termed dIL*. Logistic regression models based on sEPE grade, dIL, and clinical scores were developed to predict pathologic EPE. Results on validation set were assessed by the main metrics of the receiver operating characteristics curve (ROC) and by decision curve analysis (DCA). Based on our findings, we defined and tested an alternative sEPE grade formulation.
RESULTS: Pathologic EPE was found in 31/65 (48%) patients. Average κw was 0.65 (95% CI 0.51-0.79), 0.66 (95% CI 0.48-0.84), 0.67 (95% CI 0.50-0.84), and 0.43 (95% CI 0.22-0.63) for sEPE grading, CLL ≥ 15 mm, dIL*, and capsular bulging/irregularity, respectively. The highest diagnostic yield in predicting EPE was obtained by combining both sEPE grade and dIL*(ROC-AUC 0.81).
CONCLUSIONS: sEPE grade is reproducible and when combined with the dIL* accurately predicts extraprostatic tumor extension.
KEY POINTS: • Simple and reproducible mpMRI semi-quantitative scoring system for extraprostatic tumor extension. • sEPE grade accurately predicts extraprostatic tumor extension regardless of reader expertise. • Accurate pre-operative staging and risk stratification for optimized patient management.
引用
- Schirò, Milanese, Maddalo, et al. MR-based simplified extraprostatic extension evaluation: comparison of performances of different predictive models. Eur Radiol. 2022. PMID: 36512046. doi:10.1007/s00330-022-09240-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。